Results 121 to 130 of about 294,169 (269)
Does the teicoplanin skin test predict IgE-mediated hypersensitivity? [PDF]
Baştuğ İnan NB +3 more
europepmc +1 more source
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source
Comparative Assessment of Ibuprofen-Arginine and Potassium Nitrate-Fluoride Gels for Reducing Post-Bleaching Dentin Sensitivity: A Randomized, Double-Blind, Split-Mouth Trial. [PDF]
Colognese MRV +4 more
europepmc +1 more source
Abstract Aims Enzyme replacement therapy (ERT) for mucopolysaccharidosis II (MPS II) requires long‐term, weekly intravenous infusions often lasting over 3 h each time, which can burden paediatric patients and caregivers and negatively affect their quality of life and treatment compliance.
Kimitoshi Nakamura +6 more
wiley +1 more source
Negative Test, Persistent Avoidance: Real-World Outcomes of Quinolone De-Labeling. [PDF]
Kırdök K +12 more
europepmc +1 more source
Evaluating a virtual paediatric adverse drug reaction clinic
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck +2 more
wiley +1 more source
Clinical and behavioral determinants in pediatric non-immediate drug hypersensitivity: Low confirmation but persistent avoidance. [PDF]
Can Bostan O +3 more
europepmc +1 more source
Background By age three, 5%–75% of children have a documented antibiotic allergy (AL). Despite this prevalence, recognition remains low because of limited clinician knowledge and time. Our study evaluates a novel approach to identifying AL using electronic medical record (EMR) prescription patterns.
Georgia Koutsaplis +5 more
wiley +1 more source
Delayed Hypersensitivity Reaction to Insulin: A Case Report. [PDF]
Aharmim M +3 more
europepmc +1 more source
Aim Recovering dysbiosis may improve atopic dermatitis (AD) symptoms. XZ.700 is a recombinant chimeric endolysin that specifically targets Staphylococcus aureus and could be a new treatment option for patients with AD. The aim of this first‐in‐human study was to evaluate the safety, tolerability and efficacy of topical XZ.700 and explore the ...
Laura W. J. van der Meulen +13 more
wiley +1 more source

